Effects of plastic-foil-occlusion on psoriatic lesions.
D000135:Acid Phosphatase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D004579:Electron Transport; D003576:Electron Transport Complex IV / Q000032:analysis; D004950:Esterases / Q000032:analysis; D005122:Exudates and Transudates; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000032:analysis; D005993:Glycerolphosphate Dehydrogenase / Q000032:analysis; D006651:Histocytochemistry; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000032:analysis; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D007931:Leucyl Aminopeptidase / Q000032:analysis; D008291:Malate Dehydrogenase / Q000032:analysis; D009243:NAD / Q000032:analysis; D009249:NADP / Q000032:analysis; D010088:Oxidoreductases / Q000032:analysis; D010544:Peroxidases / Q000032:analysis; D010969:Plastics / Q000627:therapeutic use*; D011565:Psoriasis / Q000201:enzymology* / Q000473:pathology / Q000628:therapy*; D013385:Succinate Dehydrogenase / Q000032:analysis; D013778:Tetrazolium Salts; D014451:Ubiquinone / Q000032:analysis; D014867:Water / Q000378:metabolism
D010969:Plastics; D013778:Tetrazolium Salts; D014867:Water; D009243:NAD; D014451:Ubiquinone; D009249:NADP; D010088:Oxidoreductases; D005993:Glycerolphosphate Dehydrogenase; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D010544:Peroxidases; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D013385:Succinate Dehydrogenase; D003576:Electron Transport Complex IV; D004950:Esterases; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D007931:Leucyl Aminopeptidase